MCL1 as a therapeutic vulnerability in Burkitt lymphoma. Yuan R, Wang MY, Bi C, Zhao X, et al. Leukemia 2023 Feb 2. doi: 10.1038/s41375-023-01827.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yuan R, Wang MY, Bi C, Zhao X, et al. MCL1 as a therapeutic vulnerability in Burkitt lymphoma. Leukemia 2023 Feb 2. doi: 10.1038/s41375-023-01827.
PMID: 36732564